Peak's "Centennial" Ideal
Release time:
2020-07-31
Editor's Note: During the National Day, the "Jinhua New Observation" column of Jinhua TV Station launched a series of reports on "National Day New Observation: New Development of Old Enterprises" to understand those old enterprises that have grown up with New China in the new era. What kind of new development. 10# April 3 broadcast "Peak's 'Centennial Ideal" tells the development process and future development direction of Jianfeng Group.
Peak's "Centennial" Ideal
Jinhua TV Reporter Wang Dujuan Jiang Qian
Host: Speaking of Zhejiang Jianfeng Group Co., Ltd., Jinhua people are no stranger. The older generation of Jinhua people are more familiar with, may be the predecessor of Jianfeng Group-Jinhua Cement Factory.
Open the first old photo of 58 years ago, surrounded by mountains and a rice field in the middle. Old Jinhua can see at a glance that this is the Wise Temple east of Qianzhuangtou, Luodian Town, 8 kilometers from the north of Jinhua City. 1958 8 March, the first pioneers came here, with a pair of hands and a cavity of blood, built Jinhua's first cement plant on the desolate hillside of 16.94 mu.
From the earliest cattle ball forming machine to the electric ball forming machine, from pure manual labor to machine substitution, it took 26 years of hard work. By 1983 , the annual output of peak cement reached 12 tons, the output value reached 675 yuan, and the profit reached 240 yuan. In these 26 years, the cement plant experienced a difficult period of the country, the "Cultural Revolution" ten years of catastrophe, and finally ushered in a good time of reform and opening up with tenacious vitality, laying the foundation for steady development in the future.
Looking at these old photos, Jin Wengan, who entered the factory in 1970 , felt a lot. When he entered the gate of Jinhua cement factory, he was only 19 years old.
Jin Wengan, retired employee of Zhejiang Jianfeng Group Co., Ltd.: 42 , all at the peak. My lover is also at the peak, my son-in-law is also at the peak, and my brother-in-law is also at the peak. I can from a farmer to finally become a manager, science and technology personnel, are peak training.
Like Jin Wengan, Jiang Xiaomeng, chairman of Jianfeng Group, entered Jinhua Cement Factory after graduating from Senior high school. In the period of 36 , from an ordinary worker to the chairman of the group, Jiang Xiaomeng witnessed the development of Jinhua Cement Plant and now guides the transformation and upgrading of Jianfeng Group. In his view, the development of Jianfeng Group has encountered two most difficult periods. The first time was in the late 1980 s. Due to the limited scale and efficiency of the enterprise, it lacked funds for expansion and development. This hurdle prompted Jinhua Cement Plant to embark on the road of "horizontal integration", set up a cement group, and successfully carried out shareholding reform.
Jiang Xiaomeng, Chairman of Zhejiang Jianfeng Group Co., Ltd.: In Jinhua area, besides Phoenix Chemical, we are the second company officially listed on the Shanghai Stock Exchange. 1993 7 May 28 , we passed the shareholding system reform and became a listed company.
In 1993 , Peak Stock was listed on the Shanghai Stock Exchange, becoming the first listed company in the national cement industry. The stock code is 600668 . So far, the peak group still retains a sample of the stock. This stock sample also bears the signature of Du Zihong, the first-generation chairman of Jianfeng Group. Jiang Xiaomeng, Chairman of
Zhejiang Jianfeng Group Co., Ltd.: Jianfeng has gone from a single cement to absolute diversity. At most, he has made 21 kinds of products. Apart from medicine, cement and communication cables, we have done everything from mineral water and lighters to GPS system. Enterprise development will have such a process. But after the whole thing is done, you will finally focus on developing your own strengths, that is, what you can control and have the ability to do well.
In 2006 , a new crisis appeared in front of Jianfeng Group. Due to the overcapacity of cement industry losses, new investment enterprises can not play a benefit. The peak has shut down ten machine kiln production lines, with the courage of "strong men break their wrists" began to readjust the industrial layout.
Jiang Xiaomeng, Chairman of Zhejiang Jianfeng Group Co., Ltd.: We have taken the initiative to cooperate with central enterprises to convert this asset, which is relatively inefficient or inefficient in Zhejiang, into cash and invest it in the western region with more resources.
crises and sometimes opportunities. Starting from 1958 Jinhua Cement Plant, Jianfeng Group has created development opportunities and faced different development difficulties along the way. In the autumn of 2007 , Jianfeng Group took the initiative to join forces with China Building Materials Group to participate in the establishment of Southern Cement Company. Through forming a strategic alliance with central enterprises, Zhejiang cement market was integrated. In 2008 , Jianfeng Group transferred its center to places with resources and markets such as southwest and central China, successfully breaking out of the predicament.
Jiang Xiaomeng, Chairman of Zhejiang Jianfeng Group Co., Ltd.: At ordinary times, some research institutions call our business strategy "half-step philosophy", which means half a step ahead of others.
is under the guidance of this half-step philosophy. While doing a good job in the traditional cement industry, Jianfeng Group puts part of the company's focus on the development of the pharmaceutical industry. 1998 July, Zhejiang Jianfeng Pharmaceutical Co., Ltd. was established. After early market cultivation, starting from 2011 , Jianfeng Pharmaceutical introduced high-end intellectual resources, hired researcher Liu Jiajian, chief scientist of Sichuan Antibiotic Industry Research Institute, and his scientific research team, and set up Jinhua Academician Expert Workstation. This year upgraded to Zhejiang Province academician expert workstation.
Shi Cunyuan, Manager of Zhejiang Jianfeng Pharmaceutical Product Development Department: At present, we are working on 11 varieties, of which there are two national first-class innovative drugs, both of which are anti-tumor.
September 129, 2015 January, the high-tech enterprises declared by Jianfeng Group with Jianfeng Pharmaceutical Project were included in the second batch of "Three Projects" cultivation enterprises in Zhejiang Province. As of 2014 , the company has 22 valid patents for , including 21 136 for inventions, and its products are sold in 32 provinces, autonomous regions and municipalities directly under the central government in . In 2015 , the company realized sales of of 11 .3 billion yuan and paid taxes of of 5000 .45 million yuan.
At present, our Jianfeng Pharmaceutical products are mainly developed new drugs, accounting for more than 90% of the total sales volume, which is the benefit of new drug sales.
These are our main profitable varieties and also the main varieties, with considerable originality.
, Jianfeng Group integrated authoritative achievements at home and abroad and relevant resources in the enterprise to enter the big health industry.
countries now advocate moving from "treatment of existing diseases" to "preventive treatment of diseases", and the 12th Five-Year Plan for Great Health has also been released. So what does "preventive treatment" depend on? It depends on our medical treatment and health care, and prevention before disease. Therefore, we follow this logic to lay out the big health industry. Jinhua area has regional advantages and transportation advantages. On the basis of the original bonded logistics, we not only do a good job in bonded logistics, but also develop in the direction of e-commerce and third-party logistics. This will form a "two-wheel drive, two wings fly together" industrial layout.
60 years. Generations of employees have grown up alternately with the enterprise. Young employees are still working hard, and retired employees are also hard to give up. Jin Wengan, who never wanted to leave, left the enterprise after retiring in 2012 . When he had nothing to do, he would always look through the old photos and look back at that year.
As soon as I arrive in Jiangbei, I will visit our company. After all, it has been 42 years.
Jianfeng has today's development, first, thanks to our own inherent driving force for strong development; Second, there is a team that is diligent and conscientious and has worked hard for the past generations. Third, there is a good mechanism and system. Fourth, there is a good corporate culture and we have common values, there is a culture that everyone agrees. Only in this way can enterprises achieve everlasting foundation and a hundred years of peak.
years of ups and downs, the difficulties and crises experienced by enterprises, we can only look back, but can not empathize. But from the old photos, from the wrinkles on the faces of retired employees, we can see a giant with a tall and straight body, firm eyes, and steady steps. His face has left traces of time, and his eyes are still burning. Looking into the distance.
http://tv1.jinhua.com.cn/jhxgc/2016-10-03/223310.html
(top)(bottom)More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31